MacroGenics
MGNX
#8653
Rank
โ‚น22.62 B
Marketcap
โ‚น355.90
Share price
-7.73%
Change (1 day)
146.36%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น134.65

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น147.17. In 2025 the company made an earnings per share (EPS) of -โ‚น113.50 a decrease over its 2024 EPS that were of -โ‚น102.92.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น134.6518.63%
2025-โ‚น113.5010.28%
2024-โ‚น102.92613.33%
2023-โ‚น14.43-92.31%
2022-โ‚น187.57-42.14%
2021-โ‚น324.1636.44%
2020-โ‚น237.59-21.84%
2019-โ‚น303.96-24.58%
2018-โ‚น403.04675.93%
2017-โ‚น51.94-68.05%
2016-โ‚น162.56168.25%
2015-โ‚น60.60-55%
2014-โ‚น134.673400%
2013-โ‚น3.85-108.68%
2012โ‚น44.3424.49%
2011โ‚น35.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น126.01-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,715-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,393-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น713.73-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น343.87-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น342.44-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น220.28 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA